Tag - pharmaceuticals

 
 

PHARMACEUTICALS

Japan Times
JAPAN
Mar 6, 2022
Shionogi says its COVID-19 shot is effective and safe
The positive data could mean Japan, which is racing to complete a booster drive in hopes of curbing future outbreaks, will soon have an indigenous jab.
Japan Times
BUSINESS / Companies
Feb 25, 2022
Japan’s petrochemical firms need to merge to survive, Mitsubishi Chemical CEO says
Jean-Marc Gilson compared the situation facing the chemical industry to other industries Japan once dominated, such as semiconductors and flat-screen televisions.
Japan Times
JAPAN / Science & Health
Feb 25, 2022
Shionogi seeks approval for Japan’s first domestic COVID pill
Kishida has signaled that the central government will expedite the review process to pave the way for a swift approval if the drug's efficacy and safety are confirmed.
Japan Times
ASIA PACIFIC
Feb 15, 2022
China’s approval of Pfizer pill opens door to ending 'COVID zero'
Having an effective anti-viral in its arsenal could help China mitigate the lower efficacy of its homegrown vaccines if the virus was allowed to circulate more freely.
Japan Times
WORLD
Feb 14, 2022
Here’s what the pandemic has in store for the world next
As a virus-weary world limps through the third year of the outbreak, experts warn that omicron won't be the last variant we have to contend with.
Japan Times
JAPAN
Feb 8, 2022
Japan to consider early approval for Shionogi COVID-19 pill
The company could file for early approval of the drug as soon as next week, and it could deliver enough doses for 1 million people by the end of March.
Japan Times
WORLD
Feb 4, 2022
COVID’s endemic shift means a slowdown for virus product makers
Demand for at-home tests will probably slow first while sales of more reliable PCRs will show more resilience, according to medical supply executives.
Japan Times
WORLD / Science & Health
Feb 3, 2022
The COVID-19 vaccine we need now may not be a shot
Nasal vaccines may be the best way to prevent infections long term, because they provide protection exactly where it is needed to fend off the virus: the mucosal linings of the airways.
Japan Times
WORLD / Science & Health
Feb 1, 2022
How does Merck's COVID-19 pill compare to Pfizer's?
Pfizer said final trial results showed that its treatment reduced the chance of hospitalization or death by 89%, while Merck said their pill reduced those chances by 30%.
Japan Times
WORLD
Jan 27, 2022
Moderna starts trial for omicron-specific booster shot
The news comes a day after rival vaccine developer Pfizer Inc. launched a similar trial.
Japan Times
WORLD
Jan 26, 2022
Pfizer and BioNTech launch trial of omicron-targeted COVID-19 vaccine
The companies plan to test the immune response generated by the omicron-based vaccine both as a three-shot regimen in unvaccinated people and as a booster shot.
Japan Times
JAPAN
Jan 14, 2022
Pfizer seeks approval for oral COVID-19 pill in Japan
The country has already agreeing to procure enough of the drug, Paxlovid, for 2 million people
Japan Times
WORLD / Science & Health
Jan 12, 2022
Biogen stung as U.S. limits coverage of Alzheimer’s therapy
Private insurers in the U.S. have mostly declined to cover Aduhelm, saying they need more proof of its efficacy and that benefits outweigh risks like brain swelling.
Japan Times
WORLD / Science & Health
Jan 11, 2022
Singapore breaks down COVID-19 deaths by vaccine, with Moderna seeing lowest rate
While there were some caveats, the findings will likely add to concerns around the efficacy of Sinovac's and Sinopharm Group's shots, which have been widely used in the developing world.
Japan Times
WORLD / Science & Health
Jan 11, 2022
Pfizer starts making vaccine that targets both omicron and the original COVID virus
While research continues, Pfizer will evaluate the new hybrid shot against one specific to omicron and determine which should move forward by March, the firm's CEO has said.
Japan Times
BUSINESS
Dec 27, 2021
Tardy COVID-19 vaccine makers under fire for trials in developing nations
Vaccine developers at the testing phase now are seeking developing countries where vaccination rates remain low and the virus is still active.
Japan Times
JAPAN / Science & Health
Dec 24, 2021
Japan government panel approves first oral COVID-19 pill
Clinical trial data shows that patients given the pill within five days of developing symptoms were 30% less likely to be hospitalized or die.
Japan Times
WORLD
Dec 23, 2021
Pfizer pill adds to growing U.S. stockpile of COVID-19 treatments
Infections are rising across the country, but the treatments will give doctors a larger arsenal with which to fight severe coronavirus cases.
Japan Times
JAPAN / FOCUS
Dec 21, 2021
Ivermectin for COVID? Unproven treatment stokes concern in Japan
Although the treatment has received some support from Japan's medical establishment and studies are ongoing, ivermectin is not approved as a COVID-19 remedy in the country.
Japan Times
WORLD / Science & Health
Dec 20, 2021
Moderna says its booster dose appears protective against omicron
The data, which has not yet been peer reviewed, tested blood from people who had received the vaccine against a pseudovirus engineered to resemble the omicron variant.

Longform

Akiko Trush says her experience with the neurological disorder dystonia left her feeling like she wanted to chop her own hand off.
The neurological disorder that 'kills culture'